SCHEMBL9515748

SCHEMBL9515748

O=CC(c1cc(Cl)cc(Cl)c1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.39
EGFR P00533 2/20 0.39
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CASP3 P42574 9/20 0.37
CASP1 P29466 1/20 0.35
CASP2 P42575 1/20 0.35
CASP4 P49662 1/20 0.35
CASP5 P51878 1/20 0.35
CASP7 P55210 1/20 0.35
CASP6 P55212 1/20 0.35
CASP8 Q14790 1/20 0.35
FLT1 P17948 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MAP4K4 O95819 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516974 0.91 EGFR (0.44) P4HTMEGFRMEN1NPC1RAB9A
SCHEMBL9516990 0.88 P4HTM (0.37) P4HTMEGFRCASP3HDAC6SCN9A
SCHEMBL9517314 0.87 P4HTM (0.36) P4HTMEGFRCASP3HDAC6SCN9A
SCHEMBL9516948 0.85 P4HTM (0.37) P4HTMEGFRMEN1NPC1RAB9A
SCHEMBL9518019 0.84 MEN1 (0.39) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9519628 0.84 BCL2L1 (0.42) P4HTMNPC1RAB9AL3MBTL1CASP3
SCHEMBL9519311 0.83 P4HTM (0.36) P4HTMEGFRMEN1NPC1RAB9A
SCHEMBL9517025 0.83 CASP3 (0.39) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9515768 0.82 HIF1A (0.40) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9517174 0.81 HDAC1 (0.39) CASP3HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed